468 related articles for article (PubMed ID: 8951134)
1. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
2. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
3. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
5. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
Rodriguez-Alemán F; Torres JM; Cuadros JL; Ruiz E; Ortega E
Endocr Res; 2000 May; 26(2):263-73. PubMed ID: 10921452
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
9. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
10. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
Lemay A; Dodin S; Cédrin I; T-Lemay L
Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
[TBL] [Abstract][Full Text] [Related]
11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
12. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
13. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
[TBL] [Abstract][Full Text] [Related]
15. Effects of oophorectomy and hormone replacement therapy on plasma lipids.
Castelo-Branco C; Casals E; Sanllehy C; González-Merlo J; Iglesias X
Maturitas; 1993 Sep; 17(2):113-22. PubMed ID: 8231903
[TBL] [Abstract][Full Text] [Related]
16. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.
Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P
Menopause; 1998; 5(3):157-62. PubMed ID: 9774761
[TBL] [Abstract][Full Text] [Related]
18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
19. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
[TBL] [Abstract][Full Text] [Related]
20. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]